Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Switching to cyclosporine ophthalmic emulsion 0.09% ...

Julian Andrews stated that Deterra's strategy focuses on shareholder value through project development and disciplined investment in high-quality, long-life assets. He mentioned upcoming catalysts ...

IntelMarkets surpasses 120K holders while challenging the PEPE price and SHIB. With INTL tokens at $0.09, this is the last ...